Documents | Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C | Guidance | NICE

Documents

A list of downloadable documents created during development.

Background information

TA106 Hepatitis C - peginterferon alfa and ribavirin: review decision - December 2013 information
TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive ^{PDF 111.64 KB} 20 December 2013
TA106 Hepatitis C - peginterferon alfa and ribavirin: review proposal - October 2013 information
TA106 Hepatitis C - peginterferon alfa and ribavirin: - Appendix A - provisional matrix of stakeholders ^{PDF 100.31 KB} 14 October 2013
TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix B - GE Proposal Paper September 2013 ^{PDF 534.1 KB} 14 October 2013
Review decision, August 2008 information
Review decision - March 2008: table of comments ^{PDF 135.33 KB} 13 August 2008
Review proposal, March 2008 information
Thousands more people with hepatitis C to benefit from latest NICE guidance on drug treatments information
Thousands more people with hepatitis C to benefit from latest NICE guidance on drug treatments ^{PDF 42.03 KB} 23 August 2006

Hepatitis C (mild) - interferon alfa (pegylated and non-pegylated) and ribavirin (review): Final appraisal determination

Response to consultee and commentator comments on the ACD

Response to consultee and commentator comments on the ACD ^{PDF 89.68 KB} 12 May 2006

Consultee and commentator comments on the ACD

Consultee and commentator comments on the ACD
Association of Nurses in Substance Abuse ^{PDF 26.33 KB} 12 May 2006
British Society of Gastroenterology ^{PDF 18.98 KB} 12 May 2006
Department of Health Development Agency ^{PDF 43.95 KB} 12 May 2006
Foundation of Liver Research ^{PDF 31.01 KB} 10 May 2006
Haemophilia Society ^{PDF 41.96 KB} 12 May 2006
Hepatitis C Trust ^{PDF 31.92 KB} 12 May 2006
MRC Clinical Trials Unit ^{PDF 22.24 KB} 12 May 2006
NHS Quality Improvement Scotland ^{PDF 26.07 KB} 10 May 2006
Roche Products Limited ^{PDF 43.94 KB} 12 May 2006
Royal College of General Practitioners ^{PDF 58.06 KB} 12 May 2006
Royal College of Nursing ^{PDF 14.22 KB} 10 May 2006
Royal College of Pathologists ^{PDF 52.17 KB} 12 May 2006
Schering-Plough Ltd ^{PDF 37.44 KB} 10 May 2006
Welsh Assembly Government ^{PDF 42.28 KB} 12 May 2006
Welsh Assembly Government attachment ^{PDF 13.73 KB} 10 May 2006

Expert comments on the ACD

Foster ^{PDF 74.59 KB} 10 May 2006

Hepatitis C (mild) - interferon alfa (pegylated and non-pegylated) and ribavirin (review): Appraisal consultation document

Hepatitis C (mild) - interferon alfa (pegylated and non-pegylated) and ribavirin (review): Appraisal consultation document information

Final scope

Final scope ^{PDF 34.78 KB} 24 March 2005

Evaluation Report

Evaluation Report
Hepatitis C - peginterferon alfa and ribavirin: assessment report ^{PDF 1.21 MB} 17 February 2006
Overview ^{PDF 75.26 KB} 17 February 2006
Consultee and commentator comments on the assessment report
Royal College of Pathologists (2) ^{PDF 39.98 KB} 17 February 2006
Schering Plough Ltd ^{PDF 41.56 KB} 17 February 2006
CPAP ACD - Consultee and commentator comments: Royal College of Nursing ^{PDF 11.85 KB} 17 February 2006
Roche Products Ltd ^{PDF 25.39 KB} 17 February 2006
NHS Quality Improvement Scotland ^{PDF 15.88 KB} 17 February 2006
MRC Clinical Trials Unit ^{PDF 30.24 KB} 17 February 2006
Mainliners ^{PDF 32.15 KB} 17 February 2006
Haemophilia Alliance and UK Haemophilia Centre ^{PDF 13.46 KB} 17 February 2006
British Society of Gastroenterology ^{PDF 36.17 KB} 17 February 2006
British Association for the Study of the Liver ^{PDF 13.21 KB} 17 February 2006
Manufacturer submissions (executive summary only)
Schering-Plough Ltd (2) ^{PDF 19.16 KB} 17 February 2006
Roche Products Ltd (2) ^{PDF 41.82 KB} 17 February 2006
Non manufacturer submissions
Royal College of Pathologists ^{PDF 39.98 KB} 17 February 2006
Anaemia (cancer-treatment induced) - erythropoietin (alpha and beta) and darbepoetin: Appraisal consultation - Royal College of Physicians ^{PDF 21.66 KB} 17 February 2006
Royal College of Nursing (2) ^{PDF 12.9 KB} 17 February 2006
Hepatitis C Trust ^{PDF 44.73 KB} 17 February 2006
Haemophilia Society ^{PDF 41.47 KB} 17 February 2006
Expert written personal statements
Morris ^{PDF 43.13 KB} 17 February 2006
Maulayah ^{PDF 26.11 KB} 17 February 2006
Gore ^{PDF 24.41 KB} 17 February 2006
Foster ^{PDF 19.61 KB} 17 February 2006

Final Protocol

Final Protocol ^{PDF 75.14 KB} 24 March 2005

Response to consultee and commentator comments on the draft scope

Response to consultee and commentator comments on the draft scope ^{PDF 40.64 KB} 16 January 2005

Response to consultee and commentator comments on the provisional matrix of consultees and commentators

Response to consultee and commentator comments on the provisional matrix of consultees and commentators ^{PDF 21.97 KB} 16 January 2005

Archive Draft scope

Archive Draft scope ^{PDF 33.48 KB} 13 January 2005

Archive Provisional matrix of consultees and commentators

Archive Provisional matrix of consultees and commentators ^{PDF 29.51 KB} 13 January 2005